SureTrader Advertisement Advertisement
Home > Boards > US Listed > Medical - Drugs >

RXI Pharmaceuticals Corp (RXII)

Add RXII Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator nathanial, ash111, the submariner, Inoviorulez, pistol1p
Search This Board:
Last Post: 10/13/2015 12:18:20 AM - Followers: 158 - Board type: Free - Posts Today: 1

About RXi Pharmaceuticals

RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform.  Therapeutics that use RNA interference, or "RNAi," have great promise because of their ability to "silence," or down-regulate, the expression of a specific gene that may be overexpressed in a disease condition.  Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, RXi's first RNAi product candidate, RXI-109, entered into RXi's first human clinical trial in 2012.  RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation, and is initially being developed to reduce or inhibit scar formation in the skin following surgery.


RXi Pharmaceuticals Corp., has received patent approval for their new experimental breast cancer vaccine which became part of the company's arsenal after acquiring Apthera Inc. in April of this year.
The specific patents in question regard using the vaccine NeuVax with the drug Herceptin which is used in women to slow the production of the HER2 protein in tumors, while NeuVax attempts to make the body's immune system fight off cancerous cells.
According to The Telegram:
"The patents also cover using NeuVax in patients not eligible for Herceptin treatment."
With their patent in place the company plans to begin human tests in early 2012.
According to RXi the patents were developed by Dr. George E. Peoples, director of the Cancer Vaccine Development Program for the U.S. Military Cancer Institute and RXi is leasing the patents for their own work.


This May, RXi Pharmaceuticals Corp. observed two momentous events: The biotechnology company completed its spinoff from Galena Biopharma Inc., and Dr. Geert Cauwenbergh took the helm as president and chief executive officer. The small company's first product, an anti-scarring medication called RXI-109, entered clinical trials this year, and is based on the pioneering work in RNA interference of RXi scientific founder and Nobel Laureate Dr. Craig C. Mello. Dr. Cauwenbergh came to RXi after a long career in pharmaceuticals, most recently as president and chief executive officer of a company he founded, Barrier Therapeutics. What attracted you to come to Worcester? "It was the technology, well, the technology and the chemistry with these people. They're very bright." As a publicly traded company, how do you reconcile the needs of the investors, which are sometimes a short-term desire for profits, with the needs of medical research, which sometimes takes years? "Through business development. Basically what you do as a small biotech is you try to create a big network with people who have interest in various stages of development. ... In two or three years they get antsy and they want to cash in, but at that point in time there will be and there is already a network of business development contacts in place where you can for instance get nondiluted money without having to raise money and go back to the stock market and shareholders by making regional deals or geographic deals ...


June 9, 2015 RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform

Dec 17, 2014 RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301

Press Releases
RXi Pharmaceuticals to Present at Biotech Showcase™ 2013 - December 19, 2012
RXi Pharmaceuticals Announces Initiation of Second Double-Blind Vehicle Controlled Phase 1 Study With Its Anti-Scarring Compound, RXI-109 - December 5, 2012
RXi Pharmaceuticals Announces Pharmacokinetic Results of its Single Dose Phase 1 Study with RXI-109 in Healthy Volunteers - November 15, 2012
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2012 - November 14, 2012
RXi Pharmaceuticals to Present at 12th Annual Biotech Symposium - October 16, 2012
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology - October 4, 2012
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum - October 2, 2012
RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program - September 24, 2012
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2012 - August 15, 2012
RXi Pharmaceuticals Appoints Jeannette Graf MD and Leroy Young MD to its Scientific Advisory Board - July 13, 2012
Share Statistics
Avg Vol (3 month)3: 215,443
Avg Vol (10 day)3: 145,371
Shares Outstanding5: 338m
Float: 53.34M
% Held by Insiders1: 9.01%
% Held by Institutions1: 0.50%

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
News News Alert: RXi Pharmaceuticals to Present at Premier Scientific Plastic Surgery Meeting 10/12/2015 07:02:00 AM
#2282  Sticky Note RXII, DD: a solid NASDAQ stock,low market cap ash111 06/25/15 04:36:07 PM
#1762  Sticky Note FBR Capital rates RXII a "Hold" rating with Inoviorulez 04/09/15 01:56:19 PM
#2837   It has been great seeing the PPS increase InternetForumUser 10/13/15 12:18:20 AM
#2836   I see only a minor resistance at 58c Rogerthat1 10/12/15 08:03:18 PM
#2835   Always takes three! Next resistance is at 58c. The Other Guy 10/12/15 07:53:45 PM
#2834   Yep pretty much. Results in a few days, Inoviorulez 10/12/15 07:08:57 PM
#2833   53 was main resistance zone.. Broke on 3rd blackdeath 10/12/15 06:29:14 PM
#2832   Well we broke thru .52 . Next up million_dollar_mafia 10/12/15 06:10:29 PM
#2831   Probably the legendary 10 share trader is back. Hah Inoviorulez 10/12/15 05:09:10 PM
#2830   Signal??? AH trade of 10 shares at 58c. The Other Guy 10/12/15 04:29:49 PM
#2829   RXI prepping to put full-on press into motion. The Other Guy 10/12/15 12:32:28 PM
#2828   Up to 5.6. But meaningless because a The Other Guy 10/12/15 09:13:56 AM
#2827   Days to cover? million_dollar_mafia 10/12/15 09:10:14 AM
#2826   Short interest up 600k to 4.6 million. The Other Guy 10/12/15 09:05:57 AM
#2825   RXi Pharmaceuticals to Present at Premier Scientific Plastic Inoviorulez 10/12/15 07:13:56 AM
#2824   Don't tell me that I didn't warn you. Rogerthat1 10/09/15 08:30:15 PM
#2823   Friday is a bad day for me with nathanial 10/09/15 08:11:32 PM
#2822   Nice week here. More to come hopefully. nathanial 10/09/15 08:10:22 PM
#2821   $RXII here's what I'm seeing on the Ichimoku: 1. Rogerthat1 10/09/15 05:43:17 PM
#2820   Thank you. Much appreciated. Citrati 10/09/15 02:48:38 PM
#2819   From the PR for the 15th October ClosetInvester 10/09/15 02:38:47 PM
#2818   Looking for a news/event timeline the rest of Citrati 10/09/15 02:05:23 PM
#2817   Glad I got in when I did! Go $rxii Cbdpotential 10/09/15 01:22:03 PM
#2816   Cannot agree more blackdeath 10/09/15 12:03:47 PM
#2815   RXII--this is just getting started. Going way higher. $Moneypenny$ 10/09/15 11:54:42 AM
#2814   Rocking. Just the beginning $Moneypenny$ 10/09/15 11:53:48 AM
#2813   Broke through twice. It may take a third The Other Guy 10/09/15 11:24:20 AM
#2812   53 cents is key zone... blackdeath 10/09/15 10:59:36 AM
#2811   50 has a lot of resistance. But we zoriden 10/09/15 10:30:22 AM
#2810   I hope so!! JDiennoPSU 10/09/15 09:43:46 AM
#2809   Volume! Can we push through 50c? The Other Guy 10/09/15 09:36:30 AM
#2808   Yes. $Moneypenny$ 10/08/15 10:02:43 PM
#2807   I think he's referring to the AH trading. comatose 10/08/15 08:48:47 PM
#2806   What does that mean million_dollar_mafia 10/08/15 08:23:28 PM
#2805   13,000 now. $Moneypenny$ 10/08/15 07:58:43 PM
#2804   Up 2c in AH. Only 800 shares. The Other Guy 10/08/15 06:32:04 PM
#2803   This is cycling up. Should break this .47 soon. $Moneypenny$ 10/08/15 01:54:49 PM
#2802   Look at the bid and ask trading in Inoviorulez 10/08/15 11:33:55 AM
#2801   45c has now flipped to a support level. The Other Guy 10/08/15 11:30:08 AM
#2800   Looking good MM/trading computers on buy mode, not Inoviorulez 10/08/15 11:04:49 AM
#2799   Premarket is all BUYS. Good sign for the day. The Other Guy 10/08/15 09:05:16 AM
#2798   Haha I understand... But thank you for posting thehype31 10/08/15 12:18:37 AM
#2797   I am terribly upset that I have to Inoviorulez 10/07/15 08:16:13 PM
#2796   Ok, gotcha. Thanks! thehype31 10/07/15 08:02:10 PM
#2795   Scar data out on 15st. Pre clinical update Rogerthat1 10/07/15 08:01:00 PM
#2794   I see the conference announced for the 21st, thehype31 10/07/15 06:52:06 PM
#2793   Despite the MM swipe at the end we The Other Guy 10/07/15 04:22:02 PM
#2792   Way to back your claim up with facts. ClosetInvester 10/07/15 10:15:52 AM
#2791   Cool story bro JDiennoPSU 10/07/15 10:14:30 AM
#2789   Up again. Bashing here doesn't work. nathanial 10/07/15 10:08:02 AM
#2788   Looking good for that to happen. nathanial 10/07/15 09:47:33 AM
#2787   If we hold above 45c for the day The Other Guy 10/07/15 09:45:37 AM